Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma.

Baumeister SH, Murad J, Werner L, Daley H, Trebeden-Negre H, Gicobi JK, Schmucker A, Reder J, Sentman CL, Gilham DE, Lehmann FF, Galinsky I, DiPietro H, Cummings K, Munshi NC, Stone RM, Neuberg DS, Soiffer R, Dranoff G, Ritz J, Nikiforow S.

Cancer Immunol Res. 2019 Jan;7(1):100-112. doi: 10.1158/2326-6066.CIR-18-0307. Epub 2018 Nov 5.

PMID:
30396908
2.

Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients.

Esrick EB, Manis JP, Daley H, Baricordi C, Trébéden-Negre H, Pierciey FJ, Armant M, Nikiforow S, Heeney MM, London WB, Biasco L, Asmal M, Williams DA, Biffi A.

Blood Adv. 2018 Oct 9;2(19):2505-2512. doi: 10.1182/bloodadvances.2018016725.

3.

Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.

Murad JM, Baumeister SH, Werner L, Daley H, Trébéden-Negre H, Reder J, Sentman CL, Gilham D, Lehmann F, Snykers S, Sentman ML, Wade T, Schmucker A, Fanger MW, Dranoff G, Ritz J, Nikiforow S.

Cytotherapy. 2018 Jul;20(7):952-963. doi: 10.1016/j.jcyt.2018.05.001. Epub 2018 Jun 29.

PMID:
30180944
4.

Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.

Bhukhai K, de Dreuzy E, Giorgi M, Colomb C, Negre O, Denaro M, Gillet-Legrand B, Cheuzeville J, Paulard A, Trebeden-Negre H, Borwornpinyo S, Sii-Felice K, Maouche L, Down JD, Leboulch P, Payen E.

Mol Ther. 2018 Feb 7;26(2):480-495. doi: 10.1016/j.ymthe.2017.10.015. Epub 2017 Oct 24.

5.

A clinical trial combining megakaryocytes and haematopoietic stem cells to promote engraftment after autologous transplantation.

Trebeden-Negre H, Choquet S, Tanguy ML, Rozenzwajg M, Azar N, Lefrère F, Heshmati F, Belhocine R, Vieillard V, Norol F.

Br J Haematol. 2018 Oct;183(1):139-142. doi: 10.1111/bjh.14911. Epub 2017 Sep 10. No abstract available.

PMID:
28891211
6.

Polyvalent immunoglobulins, platelet lysate and lenalidomide: cocktail for polyfunctional NK cells expansion for multiple myeloma.

Trébéden-Negre H, Vieillard V, Rosenzwajg M, Garderet L, Cherai M, Nguyen-Quoc S, Tanguy ML, Norol F.

Bone Marrow Transplant. 2017 Mar;52(3):480-483. doi: 10.1038/bmt.2016.311. Epub 2016 Dec 12. No abstract available.

PMID:
27941770
7.

Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Rubio MT, Bouillié M, Bouazza N, Coman T, Trebeden-Nègre H, Gomez A, Suarez F, Sibon D, Brignier A, Paubelle E, Nguyen-Khoc S, Cavazzana M, Lantz O, Mohty M, Urien S, Hermine O.

Leukemia. 2017 Apr;31(4):903-912. doi: 10.1038/leu.2016.281. Epub 2016 Oct 14.

PMID:
27740636
8.

Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells.

Miyara M, Chader D, Burlion A, Goldstein J, Sterlin D, Norol F, Trebeden-Nègre H, Claër L, Sakaguchi S, Marodon G, Amoura Z, Gorochov G.

Oncotarget. 2016 Jul 28;8(62):104733-104744. doi: 10.18632/oncotarget.10914. eCollection 2017 Dec 1.

9.

G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease.

D'Aveni M, Rossignol J, Coman T, Sivakumaran S, Henderson S, Manzo T, Santos e Sousa P, Bruneau J, Fouquet G, Zavala F, Alegria-Prévot O, Garfa-Traoré M, Suarez F, Trebeden-Nègre H, Mohty M, Bennett CL, Chakraverty R, Hermine O, Rubio MT.

Sci Transl Med. 2015 Apr 1;7(281):281ra42. doi: 10.1126/scitranslmed.3010435.

PMID:
25834108
10.

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation.

Nguyen S, Béziat V, Norol F, Uzunov M, Trebeden-Negre H, Azar N, Boudifa A, Bories D, Debré P, Vernant JP, Vieillard V, Dhédin N.

Transfusion. 2011 Aug;51(8):1769-78. doi: 10.1111/j.1537-2995.2010.03058.x. Epub 2011 Feb 18.

PMID:
21332732
11.

Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.

Rosenzwajg M, Dhédin N, Maury S, Bensimon G, Landau DA, Norol F, Trébéden-Negre H, Uzunov M, Vernant JP, Klatzmann D, Cohen JL.

Biol Blood Marrow Transplant. 2011 Feb;17(2):265-9. doi: 10.1016/j.bbmt.2010.07.024. Epub 2010 Aug 5.

12.

Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft.

Trébéden-Negre H, Rosenzwajg M, Tanguy ML, Lefrere F, Azar N, Heshmati F, Belhocine R, Vernant JP, Klatzmann D, Norol F.

Transfusion. 2010 Dec;50(12):2649-59. doi: 10.1111/j.1537-2995.2010.02746.x.

PMID:
20576009
13.

Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer.

Lemoine FM, Cherai M, Giverne C, Dimitri D, Rosenzwajg M, Trebeden-Negre H, Chaput N, Barrou B, Thioun N, Gattegnio B, Selles F, Six A, Azar N, Lotz JP, Buzyn A, Sibony M, Delcourt A, Boyer O, Herson S, Klatzmann D, Lacave R.

Int J Oncol. 2009 Sep;35(3):569-81.

PMID:
19639177
14.

Fully functional NK cells after unrelated cord blood transplantation.

Beziat V, Nguyen S, Lapusan S, Hervier B, Dhedin N, Bories D, Uzunov M, Boudifa A, Trebeden-Negre H, Norol F, Marjanovic Z, Marie JP, Vernant JP, Debre P, Rio B, Vieillard V.

Leukemia. 2009 Apr;23(4):721-8. doi: 10.1038/leu.2008.343. Epub 2009 Jan 8.

PMID:
19151772
15.

Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.

Landau DA, Rosenzwajg M, Saadoun D, Trébeden-Negre H, Klatzmann D, Cacoub P.

Arthritis Rheum. 2008 Sep;58(9):2897-907. doi: 10.1002/art.23759.

16.

IL-2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes.

Schartz NE, Chaput N, Taieb J, Bonnaventure P, Trébeden-Nègre H, Terme M, Ménard C, Lebbé C, Schimpl A, Ardouin P, Zitvogel L.

Eur J Immunol. 2005 Oct;35(10):2840-50.

17.

Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis.

Saadoun D, Boyer O, Trébeden-Nègre H, Limal N, Bon-Durand V, Andreu M, Klatzmann D, Piette JC, Cacoub P.

J Hepatol. 2004 Dec;41(6):1031-7.

PMID:
15582138
18.

Long-term persistence of clonally expanded T cells in patients with polymyositis.

Benveniste O, Herson S, Salomon B, Dimitri D, Trébeden-Nègre H, Jean L, Bon-Durand V, Antonelli D, Klatzmann D, Boyer O.

Ann Neurol. 2004 Dec;56(6):867-72.

PMID:
15514965
19.

Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line.

Lemoine FM, Mesel-Lemoine M, Cherai M, Gallot G, Vié H, Leclercq V, Trébèden-Negre H, Mammès O, Boyer O, Noguiez-Hellin P, Klatzmann D.

J Gene Med. 2004 Apr;6(4):374-86.

PMID:
15079812
20.

B cell apoptosis accelerates the onset of murine lupus.

Trébéden-Nègre H, Weill B, Fournier C, Batteux F.

Eur J Immunol. 2003 Jun;33(6):1603-12.

Supplemental Content

Loading ...
Support Center